NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non-Hodgkin Lymphoma
Clinical trial NCT04136756 · COMPLETED
Trial details
- NCT number
- NCT04136756
- Sponsor
- Nektar Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-07
- Primary completion
- 2023-04-24
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.